Dry Eye Disease Overview
Dry eye disease (DED), also known as dry eye syndrome (DES), keratoconjunctivitis sicca (KCS), and keratitis sicca, is a multifactorial disease of the ocular surface due to a loss of homeostasis of the tear film. It often results in ocular symptoms and visual disturbance due to underlying tear film instability, ocular suface inflammation and damage, and neurosensory abnormalities.
“Dry Eye Disease Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Dry Eye Disease Market.
The Dry Eye Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Dry Eye Disease Pipeline Report:
Route of Administration
Dry Eye Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
Molecule Type
Products have been categorized under various Molecule types, such as
Dry Eye Disease Pipeline Therapeutics Assessment
DelveInsight’s Dry Eye Disease Report covers around products under different phases of clinical development like-
Some of the key companies in the Dry Eye Disease Therapeutics Market include:
Key companies developing therapies for Dry Eye Disease treatment are – AbbVie Inc. (Allergan PLC), AFT Pharmaceuticals, Akorn, Alcon Inc., Bausch Health Companies Inc., Horus Pharma, Johnson & Johnson, Mitotech, Novaliq GmbH, OASIS Medical, Otsuka Pharmaceutical Co. Ltd, Prestige Consumer Healthcare, Santen Pharmaceutical Co. Ltd, Sentiss Pharma Pvt. Ltd, Sun Pharmaceutical Industries Ltd, and VISUfarma, and others.
Emerging Dry Eye Disease Drugs Under Different Phases of Clinical Development Include:
Get a Free Sample PDF Report to know more about Dry Eye Disease Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/dry-eye-disease-pipeline-insight
Dry Eye Disease Pipeline Analysis:
The Dry Eye Disease pipeline report provides insights into
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Dry Eye Disease product details are provided in the report. Download the Dry Eye Disease pipeline report to learn more about the emerging Dry Eye Disease therapies
Dry Eye Disease Pipeline Market Drivers
Dry Eye Disease Pipeline Market Barriers
Scope of Dry Eye Disease Pipeline Drug Insight
Request for Sample PDF Report for Dry Eye Disease Pipeline Assessment and clinical trials
Table of Contents
1
Dry Eye Disease Report Introduction
2
Dry Eye Disease Executive Summary
3
4
Dry Eye Disease- Analytical Perspective In-depth Commercial Assessment
5
Dry Eye Disease Pipeline Therapeutics
6
Dry Eye Disease Late Stage Products (Phase II/III)
7
Dry Eye Disease Mid Stage Products (Phase II)
8
Dry Eye Disease Early Stage Products (Phase I)
9
Dry Eye Disease Preclinical Stage Products
10
Dry Eye Disease Therapeutics Assessment
11
Dry Eye Disease Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Dry Eye Disease Key Companies
14
Dry Eye Disease Key Products
15
Dry Eye Disease Unmet Needs
16
Dry Eye Disease Market Drivers and Barriers
17
Dry Eye Disease Future Perspectives and Conclusion
18
Dry Eye Disease Analyst Views
19
Appendix
20
About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report to know more about Dry Eye Disease drugs and therapies
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: +91 9568243403Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/consulting/r-and-d-analysis